SCHEMBL6326112

SCHEMBL6326112

CNC(=O)CN(c1cccc(NC(=C2C(=O)Nc3ccccc32)c2ccccc2)c1)S(C)(=O)=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.52
TSHR P16473 1/20 0.52
ALDH1A1 P00352 5/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
ALOX15 P16050 1/20 0.45
CYP2C19 P33261 1/20 0.45
GAA P10253 2/20 0.45
MEN1 O00255 3/20 0.44
KDM4E B2RXH2 1/20 0.44
POLB P06746 2/20 0.43
MAPT P10636 5/20 0.41
HTT P42858 3/20 0.41
NPSR1 Q6W5P4 3/20 0.40
USP2 O75604 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
LMNA P02545 3/20 0.40
PKM P14618 1/20 0.40
RECQL P46063 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6326107 1.00 KMT2A (0.52) KMT2ATSHRALDH1A1CYP3A4CYP2D6
SCHEMBL6322209 0.93 KMT2A (0.44) KMT2ATSHRALDH1A1CYP3A4CYP2D6
SCHEMBL6322220 0.93 KMT2A (0.44) KMT2ATSHRALDH1A1CYP3A4CYP2D6
SCHEMBL6318712 0.92 KMT2A (0.49) KMT2ATSHRALDH1A1CYP3A4CYP2D6
SCHEMBL6319412 0.92 KMT2A (0.49) KMT2ATSHRALDH1A1CYP3A4CYP2D6
SCHEMBL6327523 0.90 KMT2A (0.48) KMT2ATSHRALDH1A1CYP3A4CYP2D6
SCHEMBL6327526 0.90 KMT2A (0.48) KMT2ATSHRALDH1A1CYP3A4CYP2D6
SCHEMBL6318824 0.90 KMT2A (0.45) KMT2ATSHRALDH1A1GAAMEN1
SCHEMBL6320845 0.90 KMT2A (0.45) KMT2ATSHRALDH1A1GAAMEN1
SCHEMBL6319353 0.90 KMT2A (0.43) KMT2ATSHRALDH1A1CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6855710-B2 Substituted indolines with an inhibitory effect on various kinases and complexes of CDKs BOEHRINGER INGELHEIM PHARMA KG (DE) 2005-02-15 US disclosed
EP-1115704-B1 NOVEL SUBSTITUTED INDOLINONES WITH AN INHIBITORY EFFECT ON VARIOUS KINASES AND CYCLIN/CDK COMPLEXES BOEHRINGER INGELHEIM PHARMA (DE) 2003-06-18 EP disclosed